Genome‐Wide Analysis of Structural Variants in Parkinson Disease

Objective Identification of genetic risk factors for Parkinson disease (PD) has to date been primarily limited to the study of single nucleotide variants, which only represent a small fraction of the genetic variation in the human genome. Consequently, causal variants for most PD risk are not known....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of neurology 2023-05, Vol.93 (5), p.1012-1022
Hauptverfasser:	Billingsley, Kimberley J., Ding, Jinhui, Jerez, Pilar Alvarez, Illarionova, Anastasia, Levine, Kristin, Grenn, Francis P., Makarious, Mary B., Moore, Anni, Vitale, Daniel, Reed, Xylena, Hernandez, Dena, Torkamani, Ali, Ryten, Mina, Hardy, John, Chia, Ruth, Scholz, Sonja W., Traynor, Bryan J., Dalgard, Clifton L., Ehrlich, Debra J., Tanaka, Toshiko, Ferrucci, Luigi, Beach, Thomas G., Serrano, Geidy E., Quinn, John P., Bubb, Vivien J., Collins, Ryan L, Zhao, Xuefang, Walker, Mark, Pierce‐Hoffman, Emma, Brand, Harrison, Talkowski, Michael E., Casey, Bradford, Cookson, Mark R, Markham, Androo, Nalls, Mike A., Mahmoud, Medhat, Sedlazeck, Fritz J, Blauwendraat, Cornelis, Gibbs, J. Raphael, Singleton, Andrew B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Association analysis Gene deletion Gene sequencing Genetic diversity Genome, Human Genome-Wide Association Study Genomes Genotype Genotypes Health risk assessment Health risks Humans Movement disorders Neurodegenerative diseases Nucleotides Parkinson Disease - genetics Parkinson's disease Risk factors Whole Genome Sequencing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!